✦ LIBER ✦

Determinants of cardiovascular disease and other non-communicable diseases in Central and Eastern Europe: Rationale and design of the HAPIEE study

✍ Scribed by Anne Peasey; Martin Bobak; Ruzena Kubinova; Sofia Malyutina; Andrzej Pajak; Abdonas Tamosiunas; Hynek Pikhart; Amanda Nicholson; Michael Marmot

Book ID: 115014073
Publisher: BioMed Central
Year: 2006
Tongue: English
Weight: 313 KB
Volume: 6
Category: Article
ISSN: 1471-2458
DOI: 10.1186/1471-2458-6-255

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevalence of peripheral arterial diseas

Prevalence of peripheral arterial disease in patients at non-high cardiovascular risk. Rationale and design of the PANDORA study

✍ Claudio Cimminiello; Claudio Borghi; Serge Kownator; Claude Jean Wautrecht; Chri 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 193 KB

Economics of chronic diseases protocol:

Economics of chronic diseases protocol: cost-effectiveness modelling and the future burden of non-communicable disease in Europe

✍ Divajeva, Diana; Marsh, Tim; Logstrup, Susanne; Kestens, Marleen; Vemer, Pepijn; 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 178 KB

An update on cardiovascular disease epid

An update on cardiovascular disease epidemiology in South East Asia. Rationale and design of the LIFE course study in CARdiovascular disease Epidemiology (LIFECARE)

✍ E Shyong Tai; Richie Poulton; Julian Thumboo; Rody Sy; Nina Castillo-Carandang; 📂 Article 📅 2009 🏛 Elsevier 🌐 English ⚖ 210 KB

Mortality from cardiovascular and cerebr

Mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world: an update

✍ Levi, Fabio; Chatenoud, Liliane; Bertuccio, Paola; Lucchini, Francesca; Negri, E 📂 Article 📅 2009 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 794 KB

Reclassification of cardiovascular risk

Reclassification of cardiovascular risk using integrated clinical and molecular biosignatures: Design of and rationale for the Measurement to Understand the Reclassification of Disease of Cabarrus and Kannapolis (MURDOCK) Horizon 1 Cardiovascular Disease Study

✍ Svati H. Shah; Christopher B. Granger; Elizabeth R. Hauser; William E. Kraus; Ji 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 399 KB

Polypill for the prevention of cardiovas

Polypill for the prevention of cardiovascular disease (PolyIran): study design and rationale for a pragmatic cluster randomized controlled trial

✍ Ostovaneh, M. R.; Poustchi, H.; Hemming, K.; Marjani, H.; Pourshams, A.; Nateghi 📂 Article 📅 2014 🏛 SAGE Publications 🌐 English ⚖ 318 KB